• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,465.71 546.95
( 0.74%)
Global Indices
Nasdaq
50,884.98 77.97
(0.15%)
Dow Jones
7,407.31 -19.42
(-0.26%)
Hang Seng
65,160.26 1,135.66
(1.77%)
Nikkei 225
10,242.24 -130.96
(-1.26%)
Forex
USD-INR
95.53 0.30
(0.32%)
EUR-INR
110.14 0.47
(0.43%)
GBP-INR
127.43 0.45
(0.36%)
JPY-INR
0.60 0.00
(0.41%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
855.7849313
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
38.93
62288.77
EPS(TTM)
Face Value()
Div & Yield %
56.7
1
0.11
 

As on: Jun 10, 2026 12:24 PM



Particulars
Company Name Glenmark Pharmaceuticals Ltd
Face Value 1
BSE Code 532296
Year End 202603
Full Year
Equity ( in Cr.) 28.22
B.V. 855.80
Sales in Cr. 7,934.22
NP in Cr. 1,600.06
NP Var% -8.00
Div% 250.00
CPS 65.10
EPS 56.70
Traded Value( in Lakhs) 496.67
52 Week High 2,471.00
52 Week Low 1,590.00
Price BSE 2,207.00
Price NSE 2,210.00
Market Capital( in Cr.) 62,288.77
P/C Ratio 33.90
P/E Ratio 38.90
Price Vs.BV 2.58
Latest Quarter
Year End 202603
Sales in Cr. 2,207.56
NP in Cr. 294.86
NP Var % 10.00
Trailing Twelve Months
Year End 202603
Sales 8,273.06
OPM 42.29
NP 1,895.02
NP Var% -8.27
EPS 56.70
PE 38.93